Amir Nashat is the founder of Paratus Sciences. Paratus Sciences has raised $100M in total funding. Latest round: Series A. Based in New York, NY, USA.
Amir Nashat is the founding CEO of Paratus Sciences, a therapeutics discovery engine with dual sites in New York and Singapore. The company announced a $100 million Series A financing co-led by Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, and LEAPS by Bayer, with participation from Alexandria Venture Investments. Paratus Sciences uses a proprietary platform to harness the biology of bats to create novel therapeutics with an initial focus on inflammation. Nashat is also a Managing Partner at Polaris Partners, where he focuses on portfolio company executive roles and investing in healthcare companies.
Full founder directory · Investor directory · Company funding database · Fundraising library